Download Cancer - WordPress.com

Greater Manchester Cancer
Vanguard Innovation
Establishing a Cancer
Intelligence Service for Greater
Manchester and Eastern
Cheshire
28 February 2017
Greater Manchester Cancer
Vanguard Innovation
Before we start…
 There are no planned fire drills
 Toilets are in the reception area on the right
 We will be taking photos – please let us know if
you don’t want to be pictured
 Mobiles on silent please
Greater Manchester Cancer
Vanguard Innovation
Our team:
 Adrian Hackney – Project Lead
 Jac Livsey – Clinical Lead
 Catherine O’Hara – Principal Analyst
 Nadeem Ahmed – Informatics Lead
 Darren Griffiths – Associate Director (Finance)
 Tracey Wright – Service Delivery Manager
 Jon Bruce – Senior Clinical Analyst
 Emeka Eze – Senior Clinical Analyst
Greater Manchester Cancer
Vanguard Innovation
This evening’s panel:
 Adrian Hackney – Project Lead
 Jac Livsey – Clinical Lead
 Frances Cox – I Want Great Care
 Catherine O’Hara – Principal Analyst
 Nadeem Ahmed – Informatics Lead
Greater Manchester Cancer
Vanguard Innovation
The national Cancer Vanguard
• Single national Cancer Vanguard – ‘Accountable
Clinical Network for Cancer’ – Greater Manchester
Cancer Vanguard Innovation, Royal Marsden
Partners & UCLH Cancer Collaborative
• Implementing ‘Achieving World Class Cancer
Outcomes’ – to see radical improvements in
cancer outcomes
• Aligning with local Sustainability and Transformation
Planning (STP) and Cancer Board structures
• Population covered is over 10 million (2.8m in GM)
• Two-year programme testing new replicable models
of cancer care delivery and commissioning –
formally commenced in April 2016
Greater Manchester Cancer
Vanguard Innovation
What are we aiming to do?
Provide cancer intelligence for
1) Patients and their families to help
them make informed decisions
and
2) Stakeholders to ensure the best
possible delivery of, and access to,
cancer services
Greater Manchester Cancer
Vanguard Innovation
What should the intelligence service
deliver?
 Easy access to audience targeted information
 Locally relevant metrics and intelligence
 Population and sub-population specific
measures and analyses
 Timely access to information
 Investigative analysis of trends and outliers
 Asking the right questions
Greater Manchester Cancer
Vanguard Innovation
How are going to deliver intelligence for
our region?
Local
data
sources
100
75
50
0
25
% survival
Patient
reported
outcomes
PHE data
sources
0
20
40
Time from diagnosis (months)
FIGO II
late stage disease (FIGO III & IV)
60
Greater Manchester Cancer
Vanguard Innovation
What questions are important to ask?
% patients
who lived at
least one year
after
diagnosis?
Clinical
outcomes
Patient
experience
intelligence
% treated
within 62
days?
Provider
performance
% patients
diagnosed at
early stage?
How long have
you been
waiting for this
appointment?
Patient
reported
outcomes
Compared to
before your care or
treatment, how
would you rate
your quality of life?
Have you felt
involved in the
decisions
made about
your care?
Greater Manchester Cancer
Vanguard Innovation
What have we achieved so far?
 Asking users about what they want – ongoing
 Dashboard design ideas
 Access to PHE data to enable locally relevant
measures and intelligence
 Exploring access to local data sets
 iWantGreatCare
Greater Manchester Cancer
Vanguard Innovation
iWantGreatCare
●
World’s largest patient review site – over 4 million patient reviews published
●
Patient experience and outcomes in real time
●
Reviews of individual clinicians, hospitals, community services, hospices, GP practices etc.
●
Approx 100,000 new reviews every month
●
Operating internationally in 23 countries, 18 languages
●
Question sets developed and refined over 8 years to meet needs of patients and providers
●
Involved in Cancer Vanguard since Feb 2016
Greater Manchester Cancer
iWGC & the Vanguard
Vanguard Innovation
● Questions applicable to each care setting that are easy to
understand and to complete, providing the opportunity for
patients and carers to provide feedback on care and treatment
across all contact points.
● Questions devised to address some of the key indicators and outcomes of the
Vanguard, such as:
○ Respect for patient-centred values (including dignity, quality of life, shared
decisions)
○ Information and communication (on care and treatment and the involvement
of family and friends)
○ Coordination and integration of care across and within services
○ Access to care, in particular the timeliness of access to services
○ Demographics to enrich data analysis.
Greater Manchester Cancer
Vanguard Innovation
Data collection and benchmarking
● New Vanguard question sets developed in consultation with stakeholders for:
○
○
○
○
Acute setting
Community setting
Palliative Care
Paediatrics
● All question sets have questions in common with each other and with the
other questions asked by iWGC partners across the UK for cancer and noncancer care.
○ Ability to benchmark cancer services:
■ By provider
■ By care type
■ By stage of patient journey
■ Against general quality of care in the NHS
Greater Manchester Cancer
Real-time data
Vanguard Innovation
Reports will be available to staff real-time, and data analysis tools provided to
deep dive the feedback:
Greater Manchester Cancer
Vanguard Innovation
Greater Manchester Cancer
Vanguard Innovation
Our next Showcase:
CANCER PREVENTION
28 March 2017, from 5.15 pm until 6.15 pm
The Blackett Theatre, Schuster Building,
University of Manchester, Brunswick Street,
Manchester M13
Vanguard Innovation
Email: [email protected]
Web: gmcancervanguard.org
Twitter: @GM_Ca_Vanguard